Literature DB >> 21763263

ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.

Yoshiya Horimoto1, Johan Hartman, Julie Millour, Steven Pollock, Yolanda Olmos, Ka-Kei Ho, R Charles Coombes, Matti Poutanen, Sari I Mäkelä, Mona El-Bahrawy, Valerie Speirs, Eric W-F Lam.   

Abstract

In this study, we investigated the effects of ectopic estrogen receptor (ER)β1 expression in breast cancer cell lines and nude mice xenografts and observed that ERβ1 expression suppresses tumor growth and represses FOXM1 mRNA and protein expression in ERα-positive but not ERα-negative breast cancer cells. Furthermore, a significant inverse correlation exists between ERβ1 and FOXM1 expression at both protein and mRNA transcript levels in ERα-positive breast cancer patient samples. Ectopic ERβ1 expression resulted in decreased FOXM1 protein and mRNA expression only in ERα-positive but not ERα-negative breast carcinoma cell lines, suggesting that ERβ1 represses ERα-dependent FOXM1 transcription. Reporter gene assays showed that ERβ1 represses FOXM1 transcription through an estrogen-response element located within the proximal promoter region that is also targeted by ERα. The direct binding of ERβ1 to the FOXM1 promoter was confirmed by chromatin immunoprecipitation analysis, which also showed that ectopic expression of ERβ1 displaces ERα from the endogenous FOXM1 promoter. Forced expression of ERβ1 promoted growth suppression in MCF-7 cells, but the anti-proliferative effects of ERβ1 could be overridden by overexpression of FOXM1, indicating that FOXM1 is an important downstream target of ERβ1 signaling. Together, these findings define a key anti-proliferative role for ERβ1 in breast cancer development through negatively regulating FOXM1 expression.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763263      PMCID: PMC3157253          DOI: 10.1016/j.ajpath.2011.05.052

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?

Authors:  Leigh C Murphy; Peter H Watson
Journal:  Endocr Relat Cancer       Date:  2006-06       Impact factor: 5.678

Review 2.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

3.  Targeting FOXM1.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

4.  Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.

Authors:  Qiang Li; Nu Zhang; Zhiliang Jia; Xiangdong Le; Bingbing Dai; Daoyan Wei; Suyun Huang; Dongfeng Tan; Keping Xie
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

5.  Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.

Authors:  Guangfeng Zhang; Xuwan Liu; Adam M Farkas; Anil V Parwani; Kira L Lathrop; Diana Lenzner; Stephanie R Land; Harish Srinivas
Journal:  Mol Endocrinol       Date:  2008-12-23

6.  Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.

Authors:  Fumihiko Suzuki; Jun-Ichi Akahira; Ikumi Miura; Takashi Suzuki; Kiyoshi Ito; Shin-Ichi Hayashi; Hironobu Sasano; Nobuo Yaegashi
Journal:  Cancer Sci       Date:  2008-11-17       Impact factor: 6.716

7.  Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.

Authors:  Jimmy M-M Kwok; Stephen S Myatt; Charles M Marson; R Charles Coombes; Demetra Constantinidou; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

8.  Estrogen receptors and breast cancer: prognostic and therapeutic implications.

Authors:  P V Gapinski; W L Donegan
Journal:  Surgery       Date:  1980-09       Impact factor: 3.982

9.  Cloning and characterization of human estrogen receptor beta isoforms.

Authors:  J T Moore; D D McKee; K Slentz-Kesler; L B Moore; S A Jones; E L Horne; J L Su; S A Kliewer; J M Lehmann; T M Willson
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

10.  Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta.

Authors:  Wonchung Lim; Jungyoon Cho; Hyeok-yi Kwon; Yeomyeong Park; Mee-Ra Rhyu; YoungJoo Lee
Journal:  FEBS Lett       Date:  2009-03-20       Impact factor: 4.124

View more
  16 in total

Review 1.  Targeting forkhead box M1 transcription factor in breast cancer.

Authors:  Ruth M O'Regan; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2018-05-31       Impact factor: 5.858

Review 2.  Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance.

Authors:  Fung Zhao; Eric W-F Lam
Journal:  Front Med       Date:  2012-11-03       Impact factor: 4.592

3.  FoxM1 influences embryo implantation and is regulated by 17 beta-estradiol and progesterone in mouse uteri and endometrium cells.

Authors:  Yunpeng Xie; Dan Cui; Ying Kong
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 4.  Roles of FoxM1 in cell regulation and breast cancer targeting therapy.

Authors:  Xin Song; Samuel Selorm Fiati Kenston; Jinshun Zhao; Danting Yang; Yuanliang Gu
Journal:  Med Oncol       Date:  2017-02-08       Impact factor: 3.064

Review 5.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

6.  Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.

Authors:  Philip Jonsson; Anne Katchy; Cecilia Williams
Journal:  Endocr Relat Cancer       Date:  2014-01-30       Impact factor: 5.678

7.  FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.

Authors:  Guanzhen Yu; Aidong Zhou; Jianfei Xue; Chen Huang; Xia Zhang; Shin-Hyuk Kang; Wen-Tai Chiu; Christina Tan; Keping Xie; Jiejun Wang; Suyun Huang
Journal:  Oncotarget       Date:  2015-05-10

8.  Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.

Authors:  Jianxin Qian; Yizhou Luo; Xiaoqiang Gu; Wang Zhan; Xi Wang
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

Review 9.  Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance.

Authors:  Ana R Gomes; Fung Zhao; Eric W F Lam
Journal:  Chin J Cancer       Date:  2013-05-27

Review 10.  The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy.

Authors:  Raya Saba; Alhareth Alsayed; James P Zacny; Arkadiusz Z Dudek
Journal:  Int J Breast Cancer       Date:  2016-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.